SBFM
Sunshine Biopharma Inc. · Healthcare · Market cap $835K
Sunshine Biopharma Inc. (SBFM) has 2 SEC Form 4 filings (2 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: Aug 11, 2026.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Steve N. Slilaty
- Employees:50
- HQ:Fort Lauderdale, FL, US
- IPO:2022-02-15
No open-market insider trades for SBFM (Sunshine Biopharma Inc.) in the last 365 days.
Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.
Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.
Earnings: last 7 quarters
Congress trading SBFM 1 all-time
- RRep. Roger WilliamsPurchase$1,001 - $15,0002022-06-30
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does SBFM have?
Sunshine Biopharma Inc. (SBFM) has 2 SEC Form 4 filings (2 transaction rows) in the rolling 365-day window, disclosed by 0 distinct insiders. Most recent filing: Aug 11, 2026.
When was the most recent SEC Form 4 filing for SBFM?
The most recent Form 4 filing for SBFM on Tracefour is dated Aug 11, 2026.
Can I get alerts for SBFM insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Sunshine Biopharma Inc. (SBFM). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Sunshine Biopharma Inc. is in the Healthcare sector.